Key points are not available for this paper at this time.
The results of this meta-analysis and experience from long-term, open-label investigations demonstrate that the formulation of BTX-A evaluated here has a favorable safety and tolerability profile across a broad spectrum of therapeutic uses.
Naumann et al. (Wed,) studied this question.